Introduction
============

Influenza is an acute respiratory infection caused by *Myxovirus influenzae*. Worldwide, influenza causes greater morbidity than does any other infectious processes. Typically self-limiting, influenza is seen as having little relevance in its uncomplicated form and resolves spontaneously in approximately one week.^(^ [@B01] ^-^ [@B03] ^)^ The typical clinical manifestations of the uncomplicated form include fever, odynophagia, cough, myalgia, rhinitis, headache, and asthenia. In the elderly population, influenza can lead to complications, primarily viral or bacterial pneumonia.^(^ [@B04] ^)^

During influenza epidemics, the disease spreads rapidly and is responsible for high morbidity and mortality, especially in the elderly. The complications of influenza are responsible for a significant number of hospitalizations in Brazil. In 2009, 851,044 hospitalizations for influenza and pneumonia were recorded by the Hospital Information Service of the Brazilian Unified Health Care System, a figure that is 10% higher than was the average for the five years preceding that. Of all hospitalizations, 24% were for individuals 60 years of age or older.^(^ [@B03] ^)^

The elderly are the most vulnerable group to influenza, because advanced age is associated with a higher prevalence of chronic degenerative diseases and with immunological impairment. ^(^ [@B05] ^)^ The primary prevention measure is influenza vaccination, as has been recommended by the World Health Organization since 1963. In Brazil, influenza vaccination has been made available for free to the elderly throughout the country by the Brazilian National Ministry of Health since 1999. The vaccination campaign for seniors in Brazil represents a large public investment, involving an expenditure of about R\$130 million per year in the purchase and application of the vaccine, as well as in dissemination campaigns.^(^ [@B06] ^)^

Various studies, especially those conducted in the northern hemisphere, have demonstrated that the influenza vaccine is effective in the elderly, reducing morbidity and mortality.^(^ [@B07] ^,^ [@B08] ^)^ In Brazil, one group of authors observed a reduction in mortality rates one year after the vaccine intervention in the state of São Paulo.^(^ [@B09] ^)^ However, another study observed that the rates of hospitalization and death for respiratory or circulatory diseases were not reduced by vaccination in the elderly population of the city of Fortaleza, Brazil.^(^ [@B10] ^)^ The objective of the present study was to compare mortality rates for respiratory diseases among elderly individuals residing in the Federal District of Brasília, Brazil, prior to and after the implementation of a national influenza vaccination campaign in 1999.

Methods
=======

This was an ecological time series analysis involving data from the mortality records for all-cause mortality and mortality from respiratory disease in residents of Brasília who were over 60 years of age between 1996 and 2009; those data were obtained from the Mortality Database of the Brazilian National Ministry of Health Unified Health Care System.^(^ [@B11] ^)^

Estimates regarding the elderly population residing in Brasília, by age, were obtained from the Brazilian Institute of Geography and Statistics. ^(^ [@B12] ^)^ In developing countries, the United Nations considers individuals 60 years of age or older as elderly. In Brazil, Law no. 8.842/9 also classifies a person 60 years of age or older as elderly. In the present study, the elderly were divided into three age groups: 60-69 years; 70-79 years; and ≥ 80 years.

In order to determine the impact that influenza has on the community, we used the diagnoses of the following respiratory complications of viral infection: pneumonia; influenza; bronchitis; and chronic airway obstruction. For data collected up to 1997, we used the ninth revision of the International Classification of Diseases (ICD-9), and, for data collected from 1998 onward, we used the ICD-10. In the ICD-9, the codes assigned to the aforementioned diagnoses are 480-486, 487, 490-491, and 495-496, whereas those same diagnoses are coded as J10-J15, J18, J22, J40-J42, and J44, respectively, in the ICD-10. Because COPD is prevalent in patients 60 years of age or older and is frequently complicated by viral infection, leading to hospitalization and eventually to death,^(^ [@B05] ^)^ it was included in the diagnoses.

We calculated the crude (all-cause) mortality rate (CMR) for each age group (60-69 years, 70-79 years, and ≥ 80 years). In addition, we calculated the respiratory disease mortality rate (RDMR), on the basis of the classification described above, also for each of the three age groups. Subsequently, we calculated the proportional mortality ratio (PMR) for respiratory diseases, which is the ratio between the RDMR and the CMR.

Data regarding vaccination coverage in the study population were obtained from the website of the Department of Information Technology of the Brazilian National Ministry of Health Unified Health Care System and tabulated according to the area of interest (i.e., Brasília) in the specified period (1996-2009).

Results
=======

Considering 1996 as the beginning of the analysis period, we found that the CMR increased with advancing age, from 20/1,000 population in the 60- to 69-year age group to 200/1,000 in the ≥ 80-year age group ([Figure 1](#f01){ref-type="fig"}). Over the study period (1996-2009), the CMR remained mostly stable in the 60- to 69-year age group and showed a slight reduction in the 70- to 79-year age group after the implementation of the national vaccination campaign in 1999. However, in the ≥ 80-year age group, there were significant fluctuations in the CMR over that period. For that age group, despite the decrease in the CMR that occurred in 2000, the year following the implementation of the national vaccination campaign, the CMR increased gradually, reaching 200/1,000 population in 2006. It is of note that, in 2007, the CMR again showed a considerable reduction, greater than that observed in 2000, reaching approximately 150/1,000 population, and, in 2009 (end of the analysis period), it reached 130/1,000 population. Therefore, as compared with the year immediately following the implementation of the national vaccination campaign, i.e., 2000, the CMR decreased in all three age groups, and the decrease was most pronounced in the ≥ 80-year age group.

Figure 1Crude (all-cause) mortality rate (per 1,000 population) between 1996 and 2009 in the Federal District of Brasília, Brazil, by age group.

The analysis of the RDMR, as shown in [Figure 2](#f02){ref-type="fig"}, indicates that this rate clearly decreased in all three age groups over the analysis period. We found that the RDMR did not fluctuate significantly in the 60- to 69-year age group but that, in 2000, one year after the implementation of the national vaccination campaign, it decreased in the 70- to 79-year age group, a decrease followed by transient rises and then by a steady and mild decline until 2009. In the ≥ 80-year age group, the RDMR fluctuated after 2000, with moderate increases in 2001 and 2002, followed by a decrease in 2003 and marked increases in 2004 and 2005. From 2007 to 2009, there was a progressive reduction in the RDMR, which, in 2009, reached a value similar to that recorded for 2000.

Figure 2Respiratory disease mortality rate per 1,000 population between 1996 and 2009 in the Federal District of Brasília, Brazil, by age group.

The analysis of the PMR curves revealed that there was a reduction in the PMR for respiratory diseases between 1996 and 2009 for all of the age groups evaluated. However, in the 60- to 69-year age group, the PMR for respiratory diseases remained stable after 2000, whereas it continued to oscillate in the other two age groups, with occasional decreases and tendencies toward an increase throughout the period, although never again reaching the high values observed in 1996 ([Figure 3](#f03){ref-type="fig"}).

Figure 3Proportional mortality ratio for respiratory diseases between 1996 and 2009 in the Federal District of Brasília, Brazil, by age group.

[Table 1](#t01){ref-type="table"} shows that influenza vaccination coverage decreased significantly in 2000 as compared with 1999, when the national vaccination campaign was implemented. After that, between 2001 and 2009, the level of coverage fluctuated, adherence increasing between 2001 and 2003, after which there were additional fluctuations.

Table 1Influenza vaccination coverage (Brazilian National Immunization Campaign for Seniors) among individuals who were 60 years of age or older between 1999 and 2009. Federal District of Brasília, Brazil.Immunization against influenzaYear19992000200120022003200420052006200720082009Vaccination coverage[^a^](#TFN01t01){ref-type="fn"}110,6877,7480,4786,7797,6691,9389,8599,2978,2286,5587,59[^1]

Discussion
==========

In Brasília, the elderly population increases every year. In the last decade, the Brazilian population over 60 years of age has grown by 41.6%, and this growth was most significant in the ≥ 80-year age group, which increased by 60.2%.^(^ [@B10] ^)^

Individuals 80 years of age or older, designated as the very elderly, exhibit a higher prevalence of comorbidities and are at a greater risk of decompensation of their comorbidities in response to a stressor, such as influenza.^(^ [@B05] ^)^ This could explain the progressive increase in mortality from influenza in this age group. Although there were fluctuations in the CMR and the RDMR, the results of the present study indicate that there was a reduction in mortality after the implementation of the national vaccination campaign. There was a greater reduction in the PMR for respiratory diseases in those 70 years of age or older, and this can be attributed to greater vaccination coverage in this population, as has also been observed by a group of authors in the state of Paraná, Brazil.^(^ [@B13] ^)^ The greatest decline in the PMR for respiratory diseases, in all three age groups, occurred in 2000, the first year after the implementation of the national vaccination campaign. In 2001, however, the data suggest an increase in mortality from respiratory diseases in all groups. This behavior can be explained by the pattern of adherence to the influenza vaccination campaign, which was lower in 2000. The non-participation of elderly individuals in immunization campaigns reflects their attitudes and beliefs about the risks and benefits of vaccination.^(^ [@B04] ^,^ [@B06] ^,^ [@B13] ^)^

The Brazilian National Immunization Campaign for Seniors began in 1999. The target population was individuals 65 years of age or older, and 87.3% of the estimated population in this age group was vaccinated. In the subsequent year, vaccination was made available to all Brazilians 60 years of age or older. However, vaccination coverage decreased to 71.8%. In 2001, a redoubling of efforts in the campaign resulted in nationwide vaccination coverage of 82.1%.^(^ [@B05] ^)^ These data are similar to those observed in Brasília.

Studies have shown that adherence to influenza vaccination campaigns is lowest among elderly individuals between 60 and 69 years of age, especially among those with a higher level of education.^(^ [@B06] ^)^ In that age group, the PMR for respiratory diseases showed no change after the vaccine intervention. It is possible that the side effects of the vaccine, such as myalgia, low-grade fever, and malaise, can be mistaken for influenza, leading those individuals to believe that the vaccine does not protect them against influenza or even reinforcing the myth that the influenza vaccine can cause influenza.^(^ [@B05] ^)^

A number of factors are involved in the behavior of influenza and affect the complexity of the data obtained. The influenza virus exhibits antigenic variations that result in partial changes in its genetic structure. This phenomenon enables the cyclical occurrence of the disease in the population; this is possible because of the high genetic variability and adaptability of the virus. ^(^ [@B03] ^,^ [@B14] ^)^ Therefore, annual influenza vaccination is necessary.^(^ [@B02] ^)^

In Brazil, the seasonality of influenza varies from region to region, seasonal differences in frequency being more marked in regions with well-defined seasons-higher frequencies being observed in the colder months in areas with a temperate climate and in the wetter months in areas with a tropical climate. Seasonal influenza can manifest in annual outbreaks of varying size, severity, and extent that complicate the accurate diagnosis of the condition and the accurate determination of the efficacy of prophylaxis.^(^ [@B14] ^)^

In addition to the factors implicated in the difficulty in controlling influenza, another aspect that deserves attention is the increase in the circulation of other viruses with respiratory tropism. In addition to the influenza virus, the viruses most commonly associated with pulmonary infections and their complications include Respiratory syncytial virus, parainfluenza, adenovirus, rhinovirus, and metapneumovirus, the last having been identified most recently.^(^ [@B15] ^,^ [@B16] ^)^ This could explain the fluctuations observed in the present study, particularly in the ≥ 80-year age group, because that group is more susceptible to infectious diseases.

The immune system also plays an important role in disease onset and maintenance. The aging of the immune system, known as immunosenescence, is associated with the gradual deterioration of immune function, thereby increasing susceptibility to infections, autoimmune diseases, and cancer. This deterioration of immune function is associated with changes that can occur in each phase of the development of the immune response.^(^ [@B04] ^)^ The effectiveness of influenza vaccination in preventing disease is lower in elderly individuals than in younger adults, the effectiveness of vaccination ranging from 30% to 40% in the former group, compared with 70% to 90% in the latter.^(^ [@B05] ^,^ [@B17] ^,^ [@B18] ^)^

An ecological analysis has limited ability to generate causal hypotheses. In the present study, it is relevant to consider the complexity of establishing respiratory infection as the cause of death in elderly individuals, who frequently have multiple comorbidities. Underreporting or erroneous reporting of the cause of death occurs more often in the elderly population. In Brasília, the CMR can be used reliably, since the death records in Brasília cover almost all occurrences (95%).^(^ [@B19] ^)^

The present study draws attention to the potential efficacy of the influenza vaccination campaign in reducing mortality from respiratory diseases among elderly individuals residing in Brasília. The investments made in health care, with regard to the vaccination campaign, appear to have had a positive impact on the health of this population segment.
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